Elanco Animal Health (ELAN) Return on Invested Capital (2019 - 2026)
Elanco Animal Health (ELAN) reported Return on Invested Capital of 0.03% for Q1 2026, up 4.0% on a YoY basis from 0.03% in Q1 2025, and up 14.5% sequentially from 0.03% in Q4 2025.
Elanco Animal Health (ELAN) Return on Invested Capital (2019 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 8 years of Return on Invested Capital data on file, last reported at 0.03% in Q1 2026.
- For the quarter ending Q1 2026, Return on Invested Capital rose 4.0% year-over-year to 0.03%; the trailing twelve-month figure through Mar 2026 stood at 0.03% (up 4.0% YoY), and the FY2025 full-year result was 0.1%, up 35.0% from the prior year.
- Return on Invested Capital rose to 0.03% in Q1 2026, from 0.03% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.03% in Q1 2026 to a low of 0.14% in Q2 2024.
- A 5-year average of 0.03% and a median of 0.02% in 2024 frame the typical range for Return on Invested Capital.
- Across the five-year window, Return on Invested Capital fell 12 bps in 2024 and climbed 14 bps in 2025, its largest moves.
- Tracing ELAN's Return on Invested Capital over 5 years: stood at 0.03% in 2022, then tumbled by 90 bps to 0.05% in 2023, then jumped by 35 bps to 0.03% in 2024, then soared by 182 bps to 0.03% in 2025, then gained by 15 bps to 0.03% in 2026.
- Business Quant data shows ELAN's Return on Invested Capital at 0.03% in Q1 2026, 0.03% in Q4 2025, and 0.01% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 0.01% |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 0.01% |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 0.00% |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 0.03% |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.03% |
| Dec 31, 2025 | 0.03% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | -0.02% |
| Dec 31, 2024 | -0.03% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.14% |
| Mar 31, 2024 | -0.10% |
| Dec 31, 2023 | -0.05% |
| Sep 30, 2023 | -0.03% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.03% |
| Sep 30, 2022 | -0.04% |
| Jun 30, 2022 | -0.03% |
| Mar 31, 2022 | -0.02% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.02% |
| Jun 30, 2021 | -0.02% |